fbpx
Wikipedia

Hyaluronan-mediated motility receptor

May 02, 2024

Hyaluronan-mediated motility receptor (HMMR), also known as RHAMM (Receptor for Hyaluronan Mediated Motility) is a protein which in humans is encoded by the HMMR gene.[5] RHAMM recently has been also designated CD168 (cluster of differentiation 168).

HMMR
Identifiers
AliasesHMMR, CD168, IHABP, RHAMM, Hyaluronan-mediated motility receptor, hyaluronan mediated motility receptor
External IDsOMIM: 600936 MGI: 104667 HomoloGene: 8271 GeneCards: HMMR
Orthologs
SpeciesHumanMouse
Entrez

3161

15366

Ensembl

ENSG00000072571

ENSMUSG00000020330

UniProt

O75330

Q00547

RefSeq (mRNA)

NM_012485
NM_001142556
NM_001142557
NM_012484

NM_013552

RefSeq (protein)

NP_001136028
NP_001136029
NP_036616
NP_036617

NP_038580

Location (UCSC)Chr 5: 163.46 – 163.49 MbChr 11: 40.59 – 40.62 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Function edit

RHAMM was originally discovered as a soluble protein that altered migratory cell behavior and bound to hyaluronan.[6] RHAMM is less well studied than the main hyaluronan (HA) receptor, CD44. In contrast to CD44 and other cell-surface receptors which contain the classical membrane spanning domain and signal sequence for secretion from the endoplasmic reticulum / Golgi complex, RHAMM does not contain a membrane spanning domain nor does the mRNA transcript contain a signal sequence. RHAMM is localized inside the cell and is unconventionally exported to the cell surface in response to certain defined stimuli such as wounding and cytokines including TGF-β.[7] The precise unconventional export mechanism for transporting RHAMM to the extracellular space is still unclear but may involve transport channels or proteins, flippase activity, or exocytosis, similar to other non-conventionally exported cell surface proteins such as BFGF1,2 and epimorphin.[8]

Intracellularly, RHAMM associates with microtubules and, working with BRCA1 and BARD1, plays a role in the regulation of mitosis,[8][9][10] and in maintaining mitotic spindle integrity.[11] RHAMM also binds directly with ERK1 and forms complexes with ERK1,2 and MEK1,[11] suggesting a role as a scaffold protein that targets these MAP kinases to the nucleus.[12]

Extracellularly, RHAMM associates with CD44, and upon binding to hyaluronan, activates intracellular signaling pathways, mainly the MAPK pathway via ERK1,2 activation[13] Variants of RHAMM caused by alternative splicing have been observed, and alternative start codon usage has been proposed in mice and directly observed in humans.[5]

Clinical significance edit

RHAMM is over expressed in breast cancer and its expression in triple negative and HER2 subtypes is associated with poor outcome.[14] Alternatively spliced forms of RHAMM may be up regulated in some tumor types, promoting tumor progression.[15] The presence of breast tumor cell subsets with high RHAMM expression is associated with reduced metastasis free survival[16] and mediates migration, transformation, and metastatic spread of the triple negative human BCa cell line MDA-MB-231.[17]

Elevated levels of RHAMM and hyaluronan are associated with the likelihood of undergoing biochemical failure in intermediate risk prostate cancer patients.[18] RHAMM is also one of 3 biomarkers associated with aggressiveness in a multivariate analysis of human prostate tumors[19] and elevated levels of RHAMM are associated with both androgen deprivation therapy and castration resistant disease.[20] RHAMM has also been identified as one of 4 gene products identified in circulating tumor cells in patients with lung adenocarcinoma.[21]

While RHAMM has been less studied than CD44 in the process of cancer metastasis, it is likely just as important in this process and can act in concert with, or independently of CD44 to promote cell motility. Increased RHAMM expression is correlated with metastases in colorectal cancer, among others.[22] Mechanistically, RHAMM has been shown to promote cell motility through a number of different pathways. As with CD44, RHAMM can promote focal adhesion turnover by controlling focal adhesion kinase (FAK) phosphorylation and cooperating with the α4β1 and α5β1 integrins.[23] RHAMM also activates a number of downstream kinases including enhancing the intensity and sustaining the duration of ERK1 / ERK2 activation through the map kinase (MAPK) pathway, pp60 (c-src), and the downstream targets of rho kinase (ROK).[24] Finally, once a metastatic lesion has been established, RHAMM can cooperate with CD44 to promote angiogenesis by promoting migration of neighboring endothelial cells towards the tumor.[25]

References edit

  1. ^ a b c GRCh38: Ensembl release 89: ENSG00000072571 – Ensembl, May 2017
  2. ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000020330 – Ensembl, May 2017
  3. ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^ a b "Entrez Gene: HMMR hyaluronan-mediated motility receptor (RHAMM)".
  6. ^ Turley EA (Oct 1982). "Purification of a hyaluronate-binding protein fraction that modifies cell social behavior". Biochemical and Biophysical Research Communications. 108 (3): 1016–1024. doi:10.1016/0006-291X(82)92101-5. PMID 6185115.
  7. ^ Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM, Turley EA (Jun 1992). "Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility". The Journal of Cell Biology. 117 (6): 1343–1350. doi:10.1083/jcb.117.6.1343. PMC 2289508. PMID 1376732.
  8. ^ a b Maxwell CA, Keats JJ, Crainie M, Sun X, Yen T, Shibuya E, Hendzel M, Chan G, Pilarski LM (June 2003). "RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability". Molecular Biology of the Cell. 14 (6): 2262–2276. doi:10.1091/mbc.E02-07-0377. PMC 194876. PMID 12808028.
  9. ^ Joukov V, Groen AC, Prokhorova T, Gerson R, White E, Rodriguez A, Walter JC, Livingston DM (Nov 2006). "The BRCA1/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly". Cell. 127 (3): 539–552. doi:10.1016/j.cell.2006.08.053. PMID 17081976. S2CID 17769149.
  10. ^ Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, Assmann V, Elshamy WM, Rual JF, Levine D, Rozek LS, Gelman RS, Gunsalus KC, Greenberg RA, Sobhian B, Bertin N, Venkatesan K, Ayivi-Guedehoussou N, Solé X, Hernández P, Lázaro C, Nathanson KL, Weber BL, Cusick ME, Hill DE, Offit K, Livingston DM, Gruber SB, Parvin JD, Vidal M (Nov 2007). "Network modeling links breast cancer susceptibility and centrosome dysfunction". Nature Genetics. 39 (11): 1338–1349. doi:10.1038/ng.2007.2. PMID 17922014.
  11. ^ a b Tolg C, Hamilton SR, Morningstar L, Zhang J, Zhang S, Esguerra KV, Telmer PG, Luyt LG, Harrison R, McCarthy JB, Turley EA (Aug 2010). "RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity". The Journal of Biological Chemistry. 285 (34): 26461–26474. doi:10.1074/jbc.M110.121491. PMC 2924079. PMID 20558733.
  12. ^ Telmer PG, Tolg C, McCarthy JB, Turley EA (Mar 2011). "How does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression?". Communicative & Integrative Biology. 4 (2): 182–185. doi:10.4161/cib.4.2.14270. PMC 3104573. PMID 21655434.
  13. ^ Turley EA, Austen L, Vandeligt K, Clary C (Mar 1991). "Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells". The Journal of Cell Biology. 112 (5): 1041–1047. doi:10.1083/jcb.112.5.1041. PMC 2288867. PMID 1705559.
  14. ^ Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM (2004). "ONCOMINE: a cancer microarray database and integrated data-mining platform". Neoplasia. 6 (1): 1–6. doi:10.1016/S1476-5586(04)80047-2. PMC 1635162. PMID 15068665.
  15. ^ Crainie M, Belch AR, Mant MJ, Pilarski LM (Mar 1999). "Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants" (PDF). Blood. 93 (5): 1684–1696. doi:10.1182/blood.V93.5.1684. PMID 10029598.
  16. ^ Wang C, Thor AD, Moore DH, Zhao Y, Kerschmann R, Stern R, Watson PH, Turley EA (Mar 1998). "The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression". Clinical Cancer Research. 4 (3): 567–576. PMID 9533523.
  17. ^ Wang Z, Wu Y, Wang H, Zhang Y, Mei L, Fang X, Zhang X, Zhang F, Chen H, Liu Y, Jiang Y, Sun S, Zheng Y, Li N, Huang L (Jan 2014). "Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility". Proceedings of the National Academy of Sciences of the United States of America. 111 (1): E89–E98. Bibcode:2014PNAS..111E..89W. doi:10.1073/pnas.1319190110. PMC 3890879. PMID 24367099.
  18. ^ Rizzardi AE, Vogel RI, Koopmeiners JS, Forster CL, Marston LO, Rosener NK, Akentieva N, Price MA, Metzger GJ, Warlick CA, Henriksen JC, Turley EA, McCarthy JB, Schmechel SC (Jun 2014). "Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors". Cancer. 120 (12): 1800–1809. doi:10.1002/cncr.28646. PMC 4047165. PMID 24668563.
  19. ^ Rizzardi AE, Rosener NK, Koopmeiners JS, Isaksson Vogel R, Metzger GJ, Forster CL, Marston LO, Tiffany JR, McCarthy JB, Turley EA, Warlick CA, Henriksen JC, Schmechel SC (Apr 2014). "Evaluation of protein biomarkers of prostate cancer aggressiveness". BMC Cancer. 14: 244. doi:10.1186/1471-2407-14-244. PMC 4101830. PMID 24708576.
  20. ^ Korkes F, de Castro MG, de Cassio Zequi S, Nardi L, Del Giglio A, de Lima Pompeo AC (May 2014). "Hyaluronan-mediated motility receptor (RHAMM) immunohistochemical expression and androgen deprivation in normal peritumoral, hyperplasic and neoplastic prostate tissue". BJU International. 113 (5): 822–829. doi:10.1111/bju.12339. PMID 24053431. S2CID 9302075.
  21. ^ Man Y, Cao J, Jin S, Xu G, Pan B, Shang L, Che D, Yu Q, Yu Y (Sep 2014). "Newly identified biomarkers for detecting circulating tumor cells in lung adenocarcinoma". The Tohoku Journal of Experimental Medicine. 234 (1): 29–40. doi:10.1620/tjem.234.29. PMID 25175030.
  22. ^ Li H, Guo L, Li J, Liu N, Liu J (Oct 2000). "Alternative splicing of RHAMM gene in chinese gastric cancers and its in vitro regulation". Zhonghua Yi Xue Yi Chuan Xue Za Zhi = Zhonghua Yixue Yichuanxue Zazhi = Chinese Journal of Medical Genetics (in Chinese). 17 (5): 343–347. PMID 11024216.
  23. ^ Hall CL, Wang C, Lange LA, Turley EA (Jul 1994). "Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity". The Journal of Cell Biology. 126 (2): 575–588. doi:10.1083/jcb.126.2.575. PMC 2200030. PMID 7518470.
  24. ^ Hamilton SR, Fard SF, Paiwand FF, Tolg C, Veiseh M, Wang C, McCarthy JB, Bissell MJ, Koropatnick J, Turley EA (Jun 2007). "The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells". The Journal of Biological Chemistry. 282 (22): 16667–16680. doi:10.1074/jbc.M702078200. PMC 2949353. PMID 17392272.
  25. ^ Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM (Sep 2001). "Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis". The Journal of Biological Chemistry. 276 (39): 36770–36778. doi:10.1074/jbc.M102273200. PMID 11448954.

Further reading edit

  • Dawson SJ, White LA (May 1992). "Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin". The Journal of Infection. 24 (3): 317–320. doi:10.1016/S0163-4453(05)80037-4. PMID 1602151.
  • Hall CL, Yang B, Yang X, Zhang S, Turley M, Samuel S, Lange LA, Wang C, Curpen GD, Savani RC, Greenberg AH, Turley EA (Jul 1995). "Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation". Cell. 82 (1): 19–26. doi:10.1016/0092-8674(95)90048-9. PMID 7541721. S2CID 17121010.
  • Pilarski LM, Miszta H, Turley EA (May 1993). "Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells". Journal of Immunology. 150 (10): 4292–4302. doi:10.4049/jimmunol.150.10.4292. PMID 7683315.
  • Spicer AP, Roller ML, Camper SA, McPherson JD, Wasmuth JJ, Hakim S, Wang C, Turley EA, McDonald JA (Nov 1995). "The human and mouse receptors for hyaluronan-mediated motility, RHAMM, genes (HMMR) map to human chromosome 5q33.2-qter and mouse chromosome 11". Genomics. 30 (1): 115–117. doi:10.1006/geno.1995.0022. PMID 8595891.
  • Wang C, Entwistle J, Hou G, Li Q, Turley EA (Oct 1996). "The characterization of a human RHAMM cDNA: conservation of the hyaluronan-binding domains". Gene. 174 (2): 299–306. doi:10.1016/0378-1119(96)00080-7. PMID 8890751.
  • Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR (Jun 1998). "The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells". Journal of Cell Science. 111 (12): 1685–1694. doi:10.1242/jcs.111.12.1685. PMID 9601098.
  • Pilarski LM, Pruski E, Wizniak J, Paine D, Seeberger K, Mant MJ, Brown CB, Belch AR (May 1999). "Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells". Blood. 93 (9): 2918–2927. doi:10.1182/blood.V93.9.2918. PMID 10216086.
  • Assmann V, Jenkinson D, Marshall JF, Hart IR (Nov 1999). "The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments". Journal of Cell Science. 112 (22): 3943–3954. doi:10.1242/jcs.112.22.3943. PMID 10547355.
  • Lokeshwar VB, Selzer MG (Sep 2000). "Differences in hyaluronic acid-mediated functions and signaling in arterial, microvessel, and vein-derived human endothelial cells". The Journal of Biological Chemistry. 275 (36): 27641–27649. doi:10.1074/jbc.M003084200. PMID 10882722.
  • Lynn BD, Li X, Cattini PA, Nagy JI (Jun 2001). "Sequence, protein expression and extracellular-regulated kinase association of the hyaladherin RHAMM (receptor for hyaluronan mediated motility) in PC12 cells". Neuroscience Letters. 306 (1–2): 49–52. doi:10.1016/S0304-3940(01)01870-5. PMID 11403955. S2CID 38778150.
  • Lynn BD, Turley EA, Nagy JI (Jul 2001). "Subcellular distribution, calmodulin interaction, and mitochondrial association of the hyaluronan-binding protein RHAMM in rat brain". Journal of Neuroscience Research. 65 (1): 6–16. doi:10.1002/jnr.1122. PMID 11433424. S2CID 23843138.
  • Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM (Sep 2001). "Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis". The Journal of Biological Chemistry. 276 (39): 36770–36778. doi:10.1074/jbc.M102273200. PMID 11448954.
  • Akiyama Y, Jung S, Salhia B, Lee S, Hubbard S, Taylor M, Mainprize T, Akaishi K, van Furth W, Rutka JT (Jun 2001). "Hyaluronate receptors mediating glioma cell migration and proliferation". Journal of Neuro-Oncology. 53 (2): 115–127. doi:10.1023/A:1012297132047. PMID 11716065. S2CID 33691799.
  • Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Kirchner D, Krähn G, Heilmann V, Gschwend J, Bergmann L, Döhner H, Schmitt M (Sep 2002). "Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia". Experimental Hematology. 30 (9): 1029–1035. doi:10.1016/S0301-472X(02)00874-3. PMID 12225794.
  • Rein DT, Roehrig K, Schöndorf T, Lazar A, Fleisch M, Niederacher D, Bender HG, Dall P (Mar 2003). "Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis". Journal of Cancer Research and Clinical Oncology. 129 (3): 161–164. doi:10.1007/s00432-003-0415-0. PMID 12712331. S2CID 22224158.
  • Maxwell CA, Keats JJ, Crainie M, Sun X, Yen T, Shibuya E, Hendzel M, Chan G, Pilarski LM (Jun 2003). "RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability". Molecular Biology of the Cell. 14 (6): 2262–2276. doi:10.1091/mbc.E02-07-0377. PMC 194876. PMID 12808028.
  • Aziz KA (Aug 2003). "CD44 mediates polymorphonuclear leukocyte motility on hyaluronan". Saudi Medical Journal. 24 (8): 827–831. PMID 12939665.
  • Maxwell CA, Keats JJ, Belch AR, Pilarski LM, Reiman T (Feb 2005). "Receptor for hyaluronan-mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity". Cancer Research. 65 (3): 850–860. doi:10.1158/0008-5472.850.65.3. PMID 15705883. S2CID 15463595.
  • Yamasaki C, Tashiro S, Nishito Y, Sueda T, Igarashi K (Mar 2005). "Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP". Journal of Biochemistry. 137 (3): 287–296. doi:10.1093/jb/mvi031. PMID 15809329.
  • Pujana MA, Han JD, Starita LM, Stevens KN, Tewari M, Ahn JS, Rennert G, Moreno V, Kirchhoff T, Gold B, Assmann V, Elshamy WM, Rual JF, Levine D, Rozek LS, Gelman RS, Gunsalus KC, Greenberg RA, Sobhian B, Bertin N, Venkatesan K, Ayivi-Guedehoussou N, Solé X, Hernández P, Lázaro C, Nathanson KL, Weber BL, Cusick ME, Hill DE, Offit K, Livingston DM, Gruber SB, Parvin JD, Vidal M (Nov 2007). "Network modeling links breast cancer susceptibility and centrosome dysfunction". Nature Genetics. 39 (11): 1338–1349. doi:10.1038/ng.2007.2. PMID 17922014.
  • Kalmyrzaev B, Pharoah PD, Easton DF, Ponder BA, Dunning AM (Dec 2008). "Hyaluronan-mediated motility receptor gene single nucleotide polymorphisms and risk of breast cancer". Cancer Epidemiology, Biomarkers & Prevention. 17 (12): 3618–3620. doi:10.1158/1055-9965.EPI-08-0216. PMID 19064580.

This article incorporates text from the United States National Library of Medicine, which is in the public domain.

May 02, 2024
hyaluronan, mediated, motility, receptor, hmmr, also, known, rhamm, receptor, hyaluronan, mediated, motility, protein, which, humans, encoded, hmmr, gene, rhamm, recently, been, also, designated, cd168, cluster, differentiation, hmmridentifiersaliaseshmmr, cd1. Hyaluronan mediated motility receptor HMMR also known as RHAMM Receptor for Hyaluronan Mediated Motility is a protein which in humans is encoded by the HMMR gene 5 RHAMM recently has been also designated CD168 cluster of differentiation 168 HMMRIdentifiersAliasesHMMR CD168 IHABP RHAMM Hyaluronan mediated motility receptor hyaluronan mediated motility receptorExternal IDsOMIM 600936 MGI 104667 HomoloGene 8271 GeneCards HMMRGene location Human Chr Chromosome 5 human 1 Band5q34Start163 460 203 bp 1 End163 491 941 bp 1 Gene location Mouse Chr Chromosome 11 mouse 2 Band11 A5 11 24 4 cMStart40 592 222 bp 2 End40 624 249 bp 2 RNA expression patternBgeeHumanMouse ortholog Top expressed inspermtrabecular bonesecondary oocytebone marrowembryobone marrow cellstesticleappendixrectumtibiaTop expressed inPaneth cellcondylefossaatriummaxillary prominenceabdominal wallinternal carotid arteryatrioventricular valveuretervas deferensMore reference expression dataBioGPSMore reference expression dataGene ontologyMolecular functionprotein binding hyaluronic acid bindingCellular componentcytoplasm cell surface plasma membrane membrane cytosol centrosome microtubule cytoskeletonBiological processhyaluronan catabolic process regulation of G2 M transition of mitotic cell cycleSources Amigo QuickGOOrthologsSpeciesHumanMouseEntrez316115366EnsemblENSG00000072571ENSMUSG00000020330UniProtO75330Q00547RefSeq mRNA NM 012485NM 001142556NM 001142557NM 012484NM 013552RefSeq protein NP 001136028NP 001136029NP 036616NP 036617NP 038580Location UCSC Chr 5 163 46 163 49 MbChr 11 40 59 40 62 MbPubMed search 3 4 WikidataView Edit HumanView Edit Mouse Contents 1 Function 2 Clinical significance 3 References 4 Further readingFunction editRHAMM was originally discovered as a soluble protein that altered migratory cell behavior and bound to hyaluronan 6 RHAMM is less well studied than the main hyaluronan HA receptor CD44 In contrast to CD44 and other cell surface receptors which contain the classical membrane spanning domain and signal sequence for secretion from the endoplasmic reticulum Golgi complex RHAMM does not contain a membrane spanning domain nor does the mRNA transcript contain a signal sequence RHAMM is localized inside the cell and is unconventionally exported to the cell surface in response to certain defined stimuli such as wounding and cytokines including TGF b 7 The precise unconventional export mechanism for transporting RHAMM to the extracellular space is still unclear but may involve transport channels or proteins flippase activity or exocytosis similar to other non conventionally exported cell surface proteins such as BFGF1 2 and epimorphin 8 Intracellularly RHAMM associates with microtubules and working with BRCA1 and BARD1 plays a role in the regulation of mitosis 8 9 10 and in maintaining mitotic spindle integrity 11 RHAMM also binds directly with ERK1 and forms complexes with ERK1 2 and MEK1 11 suggesting a role as a scaffold protein that targets these MAP kinases to the nucleus 12 Extracellularly RHAMM associates with CD44 and upon binding to hyaluronan activates intracellular signaling pathways mainly the MAPK pathway via ERK1 2 activation 13 Variants of RHAMM caused by alternative splicing have been observed and alternative start codon usage has been proposed in mice and directly observed in humans 5 Clinical significance editRHAMM is over expressed in breast cancer and its expression in triple negative and HER2 subtypes is associated with poor outcome 14 Alternatively spliced forms of RHAMM may be up regulated in some tumor types promoting tumor progression 15 The presence of breast tumor cell subsets with high RHAMM expression is associated with reduced metastasis free survival 16 and mediates migration transformation and metastatic spread of the triple negative human BCa cell line MDA MB 231 17 Elevated levels of RHAMM and hyaluronan are associated with the likelihood of undergoing biochemical failure in intermediate risk prostate cancer patients 18 RHAMM is also one of 3 biomarkers associated with aggressiveness in a multivariate analysis of human prostate tumors 19 and elevated levels of RHAMM are associated with both androgen deprivation therapy and castration resistant disease 20 RHAMM has also been identified as one of 4 gene products identified in circulating tumor cells in patients with lung adenocarcinoma 21 While RHAMM has been less studied than CD44 in the process of cancer metastasis it is likely just as important in this process and can act in concert with or independently of CD44 to promote cell motility Increased RHAMM expression is correlated with metastases in colorectal cancer among others 22 Mechanistically RHAMM has been shown to promote cell motility through a number of different pathways As with CD44 RHAMM can promote focal adhesion turnover by controlling focal adhesion kinase FAK phosphorylation and cooperating with the a4b1 and a5b1 integrins 23 RHAMM also activates a number of downstream kinases including enhancing the intensity and sustaining the duration of ERK1 ERK2 activation through the map kinase MAPK pathway pp60 c src and the downstream targets of rho kinase ROK 24 Finally once a metastatic lesion has been established RHAMM can cooperate with CD44 to promote angiogenesis by promoting migration of neighboring endothelial cells towards the tumor 25 References edit a b c GRCh38 Ensembl release 89 ENSG00000072571 Ensembl May 2017 a b c GRCm38 Ensembl release 89 ENSMUSG00000020330 Ensembl May 2017 Human PubMed Reference National Center for Biotechnology Information U S National Library of Medicine Mouse PubMed Reference National Center for Biotechnology Information U S National Library of Medicine a b Entrez Gene HMMR hyaluronan mediated motility receptor RHAMM Turley EA Oct 1982 Purification of a hyaluronate binding protein fraction that modifies cell social behavior Biochemical and Biophysical Research Communications 108 3 1016 1024 doi 10 1016 0006 291X 82 92101 5 PMID 6185115 Hardwick C Hoare K Owens R Hohn HP Hook M Moore D Cripps V Austen L Nance DM Turley EA Jun 1992 Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility The Journal of Cell Biology 117 6 1343 1350 doi 10 1083 jcb 117 6 1343 PMC 2289508 PMID 1376732 a b Maxwell CA Keats JJ Crainie M Sun X Yen T Shibuya E Hendzel M Chan G Pilarski LM June 2003 RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability Molecular Biology of the Cell 14 6 2262 2276 doi 10 1091 mbc E02 07 0377 PMC 194876 PMID 12808028 Joukov V Groen AC Prokhorova T Gerson R White E Rodriguez A Walter JC Livingston DM Nov 2006 The BRCA1 BARD1 heterodimer modulates ran dependent mitotic spindle assembly Cell 127 3 539 552 doi 10 1016 j cell 2006 08 053 PMID 17081976 S2CID 17769149 Pujana MA Han JD Starita LM Stevens KN Tewari M Ahn JS Rennert G Moreno V Kirchhoff T Gold B Assmann V Elshamy WM Rual JF Levine D Rozek LS Gelman RS Gunsalus KC Greenberg RA Sobhian B Bertin N Venkatesan K Ayivi Guedehoussou N Sole X Hernandez P Lazaro C Nathanson KL Weber BL Cusick ME Hill DE Offit K Livingston DM Gruber SB Parvin JD Vidal M Nov 2007 Network modeling links breast cancer susceptibility and centrosome dysfunction Nature Genetics 39 11 1338 1349 doi 10 1038 ng 2007 2 PMID 17922014 a b Tolg C Hamilton SR Morningstar L Zhang J Zhang S Esguerra KV Telmer PG Luyt LG Harrison R McCarthy JB Turley EA Aug 2010 RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1 ERK1 2 activity The Journal of Biological Chemistry 285 34 26461 26474 doi 10 1074 jbc M110 121491 PMC 2924079 PMID 20558733 Telmer PG Tolg C McCarthy JB Turley EA Mar 2011 How does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression Communicative amp Integrative Biology 4 2 182 185 doi 10 4161 cib 4 2 14270 PMC 3104573 PMID 21655434 Turley EA Austen L Vandeligt K Clary C Mar 1991 Hyaluronan and a cell associated hyaluronan binding protein regulate the locomotion of ras transformed cells The Journal of Cell Biology 112 5 1041 1047 doi 10 1083 jcb 112 5 1041 PMC 2288867 PMID 1705559 Rhodes DR Yu J Shanker K Deshpande N Varambally R Ghosh D Barrette T Pandey A Chinnaiyan AM 2004 ONCOMINE a cancer microarray database and integrated data mining platform Neoplasia 6 1 1 6 doi 10 1016 S1476 5586 04 80047 2 PMC 1635162 PMID 15068665 Crainie M Belch AR Mant MJ Pilarski LM Mar 1999 Overexpression of the receptor for hyaluronan mediated motility RHAMM characterizes the malignant clone in multiple myeloma identification of three distinct RHAMM variants PDF Blood 93 5 1684 1696 doi 10 1182 blood V93 5 1684 PMID 10029598 Wang C Thor AD Moore DH Zhao Y Kerschmann R Stern R Watson PH Turley EA Mar 1998 The overexpression of RHAMM a hyaluronan binding protein that regulates ras signaling correlates with overexpression of mitogen activated protein kinase and is a significant parameter in breast cancer progression Clinical Cancer Research 4 3 567 576 PMID 9533523 Wang Z Wu Y Wang H Zhang Y Mei L Fang X Zhang X Zhang F Chen H Liu Y Jiang Y Sun S Zheng Y Li N Huang L Jan 2014 Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility Proceedings of the National Academy of Sciences of the United States of America 111 1 E89 E98 Bibcode 2014PNAS 111E 89W doi 10 1073 pnas 1319190110 PMC 3890879 PMID 24367099 Rizzardi AE Vogel RI Koopmeiners JS Forster CL Marston LO Rosener NK Akentieva N Price MA Metzger GJ Warlick CA Henriksen JC Turley EA McCarthy JB Schmechel SC Jun 2014 Elevated hyaluronan and hyaluronan mediated motility receptor are associated with biochemical failure in patients with intermediate grade prostate tumors Cancer 120 12 1800 1809 doi 10 1002 cncr 28646 PMC 4047165 PMID 24668563 Rizzardi AE Rosener NK Koopmeiners JS Isaksson Vogel R Metzger GJ Forster CL Marston LO Tiffany JR McCarthy JB Turley EA Warlick CA Henriksen JC Schmechel SC Apr 2014 Evaluation of protein biomarkers of prostate cancer aggressiveness BMC Cancer 14 244 doi 10 1186 1471 2407 14 244 PMC 4101830 PMID 24708576 Korkes F de Castro MG de Cassio Zequi S Nardi L Del Giglio A de Lima Pompeo AC May 2014 Hyaluronan mediated motility receptor RHAMM immunohistochemical expression and androgen deprivation in normal peritumoral hyperplasic and neoplastic prostate tissue BJU International 113 5 822 829 doi 10 1111 bju 12339 PMID 24053431 S2CID 9302075 Man Y Cao J Jin S Xu G Pan B Shang L Che D Yu Q Yu Y Sep 2014 Newly identified biomarkers for detecting circulating tumor cells in lung adenocarcinoma The Tohoku Journal of Experimental Medicine 234 1 29 40 doi 10 1620 tjem 234 29 PMID 25175030 Li H Guo L Li J Liu N Liu J Oct 2000 Alternative splicing of RHAMM gene in chinese gastric cancers and its in vitro regulation Zhonghua Yi Xue Yi Chuan Xue Za Zhi Zhonghua Yixue Yichuanxue Zazhi Chinese Journal of Medical Genetics in Chinese 17 5 343 347 PMID 11024216 Hall CL Wang C Lange LA Turley EA Jul 1994 Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity The Journal of Cell Biology 126 2 575 588 doi 10 1083 jcb 126 2 575 PMC 2200030 PMID 7518470 Hamilton SR Fard SF Paiwand FF Tolg C Veiseh M Wang C McCarthy JB Bissell MJ Koropatnick J Turley EA Jun 2007 The hyaluronan receptors CD44 and Rhamm CD168 form complexes with ERK1 2 that sustain high basal motility in breast cancer cells The Journal of Biological Chemistry 282 22 16667 16680 doi 10 1074 jbc M702078200 PMC 2949353 PMID 17392272 Savani RC Cao G Pooler PM Zaman A Zhou Z DeLisser HM Sep 2001 Differential involvement of the hyaluronan HA receptors CD44 and receptor for HA mediated motility in endothelial cell function and angiogenesis The Journal of Biological Chemistry 276 39 36770 36778 doi 10 1074 jbc M102273200 PMID 11448954 Further reading editDawson SJ White LA May 1992 Treatment of Haemophilus aphrophilus endocarditis with ciprofloxacin The Journal of Infection 24 3 317 320 doi 10 1016 S0163 4453 05 80037 4 PMID 1602151 Hall CL Yang B Yang X Zhang S Turley M Samuel S Lange LA Wang C Curpen GD Savani RC Greenberg AH Turley EA Jul 1995 Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H ras transformation Cell 82 1 19 26 doi 10 1016 0092 8674 95 90048 9 PMID 7541721 S2CID 17121010 Pilarski LM Miszta H Turley EA May 1993 Regulated expression of a receptor for hyaluronan mediated motility on human thymocytes and T cells Journal of Immunology 150 10 4292 4302 doi 10 4049 jimmunol 150 10 4292 PMID 7683315 Spicer AP Roller ML Camper SA McPherson JD Wasmuth JJ Hakim S Wang C Turley EA McDonald JA Nov 1995 The human and mouse receptors for hyaluronan mediated motility RHAMM genes HMMR map to human chromosome 5q33 2 qter and mouse chromosome 11 Genomics 30 1 115 117 doi 10 1006 geno 1995 0022 PMID 8595891 Wang C Entwistle J Hou G Li Q Turley EA Oct 1996 The characterization of a human RHAMM cDNA conservation of the hyaluronan binding domains Gene 174 2 299 306 doi 10 1016 0378 1119 96 00080 7 PMID 8890751 Assmann V Marshall JF Fieber C Hofmann M Hart IR Jun 1998 The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells Journal of Cell Science 111 12 1685 1694 doi 10 1242 jcs 111 12 1685 PMID 9601098 Pilarski LM Pruski E Wizniak J Paine D Seeberger K Mant MJ Brown CB Belch AR May 1999 Potential role for hyaluronan and the hyaluronan receptor RHAMM in mobilization and trafficking of hematopoietic progenitor cells Blood 93 9 2918 2927 doi 10 1182 blood V93 9 2918 PMID 10216086 Assmann V Jenkinson D Marshall JF Hart IR Nov 1999 The intracellular hyaluronan receptor RHAMM IHABP interacts with microtubules and actin filaments Journal of Cell Science 112 22 3943 3954 doi 10 1242 jcs 112 22 3943 PMID 10547355 Lokeshwar VB Selzer MG Sep 2000 Differences in hyaluronic acid mediated functions and signaling in arterial microvessel and vein derived human endothelial cells The Journal of Biological Chemistry 275 36 27641 27649 doi 10 1074 jbc M003084200 PMID 10882722 Lynn BD Li X Cattini PA Nagy JI Jun 2001 Sequence protein expression and extracellular regulated kinase association of the hyaladherin RHAMM receptor for hyaluronan mediated motility in PC12 cells Neuroscience Letters 306 1 2 49 52 doi 10 1016 S0304 3940 01 01870 5 PMID 11403955 S2CID 38778150 Lynn BD Turley EA Nagy JI Jul 2001 Subcellular distribution calmodulin interaction and mitochondrial association of the hyaluronan binding protein RHAMM in rat brain Journal of Neuroscience Research 65 1 6 16 doi 10 1002 jnr 1122 PMID 11433424 S2CID 23843138 Savani RC Cao G Pooler PM Zaman A Zhou Z DeLisser HM Sep 2001 Differential involvement of the hyaluronan HA receptors CD44 and receptor for HA mediated motility in endothelial cell function and angiogenesis The Journal of Biological Chemistry 276 39 36770 36778 doi 10 1074 jbc M102273200 PMID 11448954 Akiyama Y Jung S Salhia B Lee S Hubbard S Taylor M Mainprize T Akaishi K van Furth W Rutka JT Jun 2001 Hyaluronate receptors mediating glioma cell migration and proliferation Journal of Neuro Oncology 53 2 115 127 doi 10 1023 A 1012297132047 PMID 11716065 S2CID 33691799 Greiner J Ringhoffer M Taniguchi M Schmitt A Kirchner D Krahn G Heilmann V Gschwend J Bergmann L Dohner H Schmitt M Sep 2002 Receptor for hyaluronan acid mediated motility RHAMM is a new immunogenic leukemia associated antigen in acute and chronic myeloid leukemia Experimental Hematology 30 9 1029 1035 doi 10 1016 S0301 472X 02 00874 3 PMID 12225794 Rein DT Roehrig K Schondorf T Lazar A Fleisch M Niederacher D Bender HG Dall P Mar 2003 Expression of the hyaluronan receptor RHAMM in endometrial carcinomas suggests a role in tumour progression and metastasis Journal of Cancer Research and Clinical Oncology 129 3 161 164 doi 10 1007 s00432 003 0415 0 PMID 12712331 S2CID 22224158 Maxwell CA Keats JJ Crainie M Sun X Yen T Shibuya E Hendzel M Chan G Pilarski LM Jun 2003 RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability Molecular Biology of the Cell 14 6 2262 2276 doi 10 1091 mbc E02 07 0377 PMC 194876 PMID 12808028 Aziz KA Aug 2003 CD44 mediates polymorphonuclear leukocyte motility on hyaluronan Saudi Medical Journal 24 8 827 831 PMID 12939665 Maxwell CA Keats JJ Belch AR Pilarski LM Reiman T Feb 2005 Receptor for hyaluronan mediated motility correlates with centrosome abnormalities in multiple myeloma and maintains mitotic integrity Cancer Research 65 3 850 860 doi 10 1158 0008 5472 850 65 3 PMID 15705883 S2CID 15463595 Yamasaki C Tashiro S Nishito Y Sueda T Igarashi K Mar 2005 Dynamic cytoplasmic anchoring of the transcription factor Bach1 by intracellular hyaluronic acid binding protein IHABP Journal of Biochemistry 137 3 287 296 doi 10 1093 jb mvi031 PMID 15809329 Pujana MA Han JD Starita LM Stevens KN Tewari M Ahn JS Rennert G Moreno V Kirchhoff T Gold B Assmann V Elshamy WM Rual JF Levine D Rozek LS Gelman RS Gunsalus KC Greenberg RA Sobhian B Bertin N Venkatesan K Ayivi Guedehoussou N Sole X Hernandez P Lazaro C Nathanson KL Weber BL Cusick ME Hill DE Offit K Livingston DM Gruber SB Parvin JD Vidal M Nov 2007 Network modeling links breast cancer susceptibility and centrosome dysfunction Nature Genetics 39 11 1338 1349 doi 10 1038 ng 2007 2 PMID 17922014 Kalmyrzaev B Pharoah PD Easton DF Ponder BA Dunning AM Dec 2008 Hyaluronan mediated motility receptor gene single nucleotide polymorphisms and risk of breast cancer Cancer Epidemiology Biomarkers amp Prevention 17 12 3618 3620 doi 10 1158 1055 9965 EPI 08 0216 PMID 19064580 This article incorporates text from the United States National Library of Medicine which is in the public domain Retrieved from https en wikipedia org w index php title Hyaluronan mediated motility receptor amp oldid 1191694505, wikipedia, wiki, book, books, library,

article

, read, download, free, free download, mp3, video, mp4, 3gp, jpg, jpeg, gif, png, picture, music, song, movie, book, game, games.